In a press conference held on Saturday (27), the Ministry of Health announced a partnership with the University of Oxford, uk, and the pharmaceutical AstraZeneca, for the research and production of doses of the vaccine in tests against Covid-19 within Brazil.
At first, the Brazilian government is expected to buy 30.4 million doses of ChAdOx1 in two batches – scheduled for December 2020 and January 2021 – and the transfer of technology in order to have local manufacturing.
The Oswaldo Cruz Foundation (Fiocruz) will be in charge of the development of the vaccine within the country. According to the agreement signed, Brazil has committed to invest US$ 127 million in the entire development process – of which US$ 30 million is for production only.
The Ministry of Health said it could guarantee the supply of at least 100 million doses of the vaccine in the country as of December. That is, if the testing process follows the expected time limits and its efficacy and safety in human application are proven.